Aprea Therapeutics, Inc. (APRE) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Aprea Therapeutics, Inc. (APRE) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $5.8M, listed on NASDAQ, employing roughly 8 people, carrying a beta of 1.48 to the broader market. Aprea Therapeutics, Inc. Led by Oren Gilad, public since 2019-10-03.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for APRE as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →